• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Technology·NRO.PA
Share

Neurones S.A. Stocks

€ 36.5Last Updated 23.10.2026

Issuer Rating

6/7
Performance

Strong

Risk

Limited

Recommendation

Buy

Market Cap

€ 990.42M

€ 36.5
Key Takeaways

Risk factor

Poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Neurones S.A., an information technology (IT) services provider founded in 1984 and headquartered in Nanterre, France, operates with a global reach. The company delivers a broad spectrum of services encompassing infrastructure, application development, and strategic consulting. Its infrastructure capabilities include comprehensive management, cloud solutions, user support, DevOps implementation, robust cybersecurity measures, IT service management, system governance, and automation. For applications, Neurones specializes in SAP integration and outsourcing, mobile development, data management, IoT, digital platform creation, agile methodologies, and user experience (UX/UI). They also provide IT consulting focused on finance, big data, artificial intelligence, and blockchain, alongside content and business process management, paperless solutions, and IT training with change management. The company offers extensive consulting services, including strategic management and digital transformation guidance, as well as digital marketing expertise. These transformation services span areas such as agile/Scrum adoption, DevOps, CI/CD, cloud computing, infrastructure as code, advanced cybersecurity, analytics, big data, mobility, digital workplace solutions, connected devices, and innovative technologies, client experience, UX/UI, and digital marketing. Furthermore, they facilitate internal process digitization through ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain. Managed services and outsourcing solutions are also core offerings. Neurones serves a diverse clientele across various sectors, including banking and insurance, consumer goods and services, energy, utilities, healthcare, technology, media, telecoms, industrial, public works and civil engineering, and public administration.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of NRO.PA is 45.0 and suggests 23.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.10.2026 13:01

AI investors are already on the brink, a “French kiss” for the euro, and hackers at the gates

24.10.2026 05:04

Hedge funds have ramped up their bets against the euro to a 2020 high

24.10.2026 04:46

France Avoided a Downgrade by Moody’s After a Week of Crisis

24.10.2026 04:37

A key Novartis drug failed to meet expectations. The stock price fell

24.10.2026 03:14

Hugo Boss Will Still Become a "Subsidiary" of the British Retailer Despite the Collapse of the Takeover

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026